NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

IndexS&P 500 P/E35.20 EPS (ttm)6.37 Insider Own0.64% Shs Outstand71.80M Perf Week2.37%
Market Cap16.11B Forward P/E31.52 EPS next Y7.11 Insider Trans0.00% Shs Float71.39M Perf Month6.43%
Enterprise Value16.01B PEG6.47 EPS next Q1.51 Inst Own97.89% Short Float2.92% Perf Quarter1.21%
Income467.20M P/S5.56 EPS this Y-6.79% Inst Trans-0.03% Short Ratio2.60 Perf Half Y-31.82%
Sales2.90B P/B6.00 EPS next Y13.04% ROA12.94% Short Interest2.08M Perf YTD-31.56%
Book/sh37.37 P/C39.85 EPS next 5Y5.44% ROE17.42% 52W High352.33 -36.37% Perf Year-30.93%
Cash/sh5.63 P/FCF52.48 EPS past 3/5Y-8.31% 15.84% ROIC15.74% 52W Low187.43 19.61% Perf 3Y-24.38%
Dividend Est.0.51 (0.23%) EV/EBITDA21.14 Sales past 3/5Y0.72% 9.43% Gross Margin34.66% Volatility2.71% 2.64% Perf 5Y0.78%
Dividend TTM0.83 (0.37%) EV/Sales5.53 EPS Y/Y TTM-16.35% Oper. Margin20.64% ATR (14)5.70 Perf 10Y280.68%
Dividend Ex-DateJul 30, 2025 Quick Ratio2.03 Sales Y/Y TTM-1.14% Profit Margin16.13% RSI (14)57.89 Recom1.53
Dividend Gr. 3/5Y5.42% 5.75% Current Ratio2.77 EPS Q/Q-20.73% SMA201.29% Beta1.04 Target Price271.82
Payout12.27% Debt/Eq0.11 Sales Q/Q0.42% SMA503.88% Rel Volume0.44 Prev Close221.22
Employees10600 LT Debt/Eq0.11 EarningsApr 24 BMO SMA200-16.91% Avg Volume800.48K Price224.18
IPOMar 17, 1980 Option/ShortYes / Yes EPS/Sales Surpr.18.13% 1.80% Trades Volume183,524 Change1.34%
Date Action Analyst Rating Change Price Target Change
Jun-24-25Initiated Barclays Equal Weight $245
Mar-18-25Initiated Evercore ISI Outperform $275
Feb-14-25Upgrade Deutsche Bank Hold → Buy $250
Jan-08-25Initiated Citigroup Buy $400
Dec-13-24Initiated Wolfe Research Peer Perform
Dec-12-24Upgrade UBS Neutral → Buy $350 → $390
Feb-07-24Upgrade Jefferies Hold → Buy $323 → $536
Jun-16-23Upgrade BofA Securities Neutral → Buy $390 → $405
Apr-11-23Upgrade Stephens Equal-Weight → Overweight $330 → $400
Dec-14-22Initiated Deutsche Bank Hold $250
Today 10:07AM
Jun-26-25 08:46AM
08:45AM
Jun-20-25 09:51AM
09:00AM
05:45AM Loading…
Jun-13-25 05:45AM
Jun-10-25 08:21PM
09:55AM
May-30-25 01:06AM
May-29-25 11:30AM
May-20-25 05:45AM
May-19-25 12:00PM
09:55AM
May-14-25 04:25AM
May-09-25 12:39AM
04:30PM Loading…
May-07-25 04:30PM
May-03-25 10:39PM
May-02-25 09:33AM
08:24AM
12:42AM
May-01-25 10:58PM
Apr-30-25 07:41PM
Apr-29-25 09:30PM
08:07PM
09:03AM
Apr-28-25 09:05AM
03:08AM
Apr-26-25 01:53AM
Apr-25-25 02:47AM
Apr-24-25 06:03PM
03:52PM Loading…
03:52PM
11:36AM
07:10AM
06:10AM
06:09AM
06:07AM
06:00AM
01:15AM
Apr-23-25 08:06AM
Apr-22-25 08:12AM
Apr-18-25 09:36AM
Apr-17-25 10:01AM
Apr-15-25 10:06AM
Apr-10-25 01:33PM
06:00AM
Apr-08-25 05:11AM
Apr-04-25 08:03PM
Apr-03-25 11:28PM
09:32AM
Mar-31-25 04:07PM
Mar-28-25 11:30AM
Mar-27-25 11:30AM
Mar-25-25 05:07AM
Mar-09-25 08:51PM
Mar-05-25 06:00AM
Feb-28-25 07:21PM
Feb-20-25 04:30PM
Feb-19-25 10:36PM
Feb-17-25 09:37AM
Feb-14-25 11:49AM
07:51AM
02:14AM
Feb-13-25 07:22PM
01:48PM
12:51PM
11:29AM
07:10AM
06:18AM
06:05AM
06:00AM
Feb-12-25 08:51AM
08:03AM
Jan-30-25 06:00AM
Jan-28-25 12:00PM
Jan-22-25 10:36AM
06:00AM
Jan-06-25 04:30PM
Dec-14-24 06:45AM
Dec-13-24 08:00AM
Dec-11-24 06:00AM
Dec-10-24 09:31AM
Nov-27-24 09:04AM
Nov-16-24 10:12AM
Oct-30-24 12:15PM
Oct-29-24 06:00AM
Oct-26-24 01:03AM
Oct-25-24 08:16AM
03:11AM
Oct-24-24 08:50PM
05:12PM
01:09PM
07:10AM
06:07AM
06:00AM
Oct-22-24 12:02PM
06:00AM
Oct-17-24 10:01AM
Oct-10-24 06:00AM
Oct-09-24 06:00AM
Oct-07-24 09:54PM
West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. It operates through the Proprietary Products and Contract-Manufactured Products segments. The Proprietary Products segment offers proprietary packaging, containment solutions and drug delivery products, along with analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Birkett BernardSr VP, Chief Financial OfficerFeb 18 '25Option Exercise211.00904190,8147,669Feb 20 09:44 PM
Reiss-Clark CindyChief Commercial OfficerFeb 18 '25Option Exercise211.0024651,9405,131Feb 20 09:16 PM
MacKay Kimberly BanksSVP, GC & Corporate SecretaryFeb 18 '25Option Exercise211.0024651,9401,605Feb 20 09:13 PM
Favorite Annette FSr. VP & Chief HR OfficerFeb 18 '25Option Exercise211.0024651,9406,823Feb 20 09:11 PM
Winters ChadVP, Chief Accounting OfficerFeb 18 '25Option Exercise211.008217,3131,391Feb 20 09:09 PM
Witherspoon CharlesVP & TreasurerFeb 18 '25Option Exercise211.006613,8641,319Feb 20 09:08 PM
Green Eric MarkPresident, CEO and Board ChairFeb 18 '25Option Exercise211.002,461519,269170,369Feb 20 09:06 PM
Witherspoon CharlesVP & TreasurerOct 29 '24Option Exercise173.2247882,7991,956Oct 31 12:05 PM
Witherspoon CharlesVP & TreasurerOct 29 '24Sale310.40703218,2111,253Oct 31 12:05 PM
Abraham SiljiSVP, Chief Technology OfficerOct 29 '24Option Exercise0.0045803,318Oct 31 11:50 AM
Witherspoon CharlesVP & TreasurerAug 19 '24Option Exercise102.5152954,2282,507Aug 21 05:02 PM
Witherspoon CharlesVP & TreasurerAug 19 '24Sale300.001,029308,7001,478Aug 21 05:02 PM
Green Eric MarkPresident, CEO and Board ChairAug 06 '24Option Exercise59.6436,7322,190,696192,640Aug 08 04:16 PM
Green Eric MarkPresident, CEO and Board ChairAug 06 '24Sale304.7130,7329,364,409161,898Aug 08 04:16 PM
Green Eric MarkOfficerAug 06 '24Proposed Sale304.7130,7329,364,409Aug 06 04:47 PM